BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24397594)

  • 41. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
    Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
    Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): a case report.
    Schroeder T; Hildebrandt B; Mayatepek E; Germing U; Haas R
    J Med Case Rep; 2008 Sep; 2():319. PubMed ID: 18826620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3.
    Grigg AP; Gascoyne RD; Phillips GL; Horsman DE
    Br J Haematol; 1993 Jan; 83(1):158-65. PubMed ID: 8435325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7.
    Müller CI; Engelhardt M; Laubenberger J; Kunzmann R; Engelhardt R; Lübbert M
    Eur J Haematol; 2002 Aug; 69(2):115-9. PubMed ID: 12366717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acute myeloid leukemia with t (3;8) (q26.2;q24), a simple variant of 3q26.2/EVI1 translocation].
    Sato K; Sakai H; Uchida A; Uemura Y; Tsuruoka Y; Yokoi S; Nishio Y; Matsunawa M; Suzuki Y; Isobe Y; Kato M; Tomita N; Inoue Y; Miura I
    Rinsho Ketsueki; 2017; 58(4):315-322. PubMed ID: 28484159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Myelodysplastic syndrome / acute myeloid leukemia with t(8; 21) and bundle of Auer rods in neutrophils: an unusual hemopathy].
    Kallel C; Makni F; Bouzidi H; Hdiji S; Elloumi M; Souissi T; Ellouz F
    Ann Biol Clin (Paris); 2005; 63(4):429-32. PubMed ID: 16061442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New case of t(3;17)(q26;q22) as an additional change in a Philadelphia-positive chronic myelogenous leukemia in acceleration.
    Mugneret F; Solary E; Favre B; Caillot D; Sidaner I; Guy H
    Cancer Genet Cytogenet; 1992 May; 60(1):90-2. PubMed ID: 1591713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. JAK2 V617F mutation in myeloid neoplasms with 3q21 and 3q26 abnormalities in Chinese patients.
    Wong KF; Wong WS; Siu LL; Lau TC
    Leuk Lymphoma; 2009 Aug; 50(8):1386-8. PubMed ID: 19562620
    [No Abstract]   [Full Text] [Related]  

  • 49. Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7).
    Jarmuz M; Kroll R; Przybyłowicz-Chalecka A; Ratajczak B; Gniot M; Szyfter K; Komarnicki M
    Cancer Genet Cytogenet; 2010 May; 199(1):45-7. PubMed ID: 20417868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. t(2;3)(p13;q26) in a case of chronic myeloid leukemia. Importance of the involvement of 3q26.
    Kwong YL; Chan LC; Lie KW
    Cancer Genet Cytogenet; 1992 Mar; 59(1):95-6. PubMed ID: 1555200
    [No Abstract]   [Full Text] [Related]  

  • 51. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translocation (3;21) in Philadelphia positive chronic myeloid leukemia: high resolution chromosomal analysis and immunological study on five new cases.
    Lafage-Pochitaloff-Huvalé M; Sainty D; Adriaanssen HJ; Lopez M; Maraninchi D; Simonetti J; Mannoni P; Carcassonne Y; Hagemeijer A
    Leukemia; 1989 Aug; 3(8):554-9. PubMed ID: 2747289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors.
    Theil KS; Cotta CV
    Cancer Genet; 2014 May; 207(5):171-6. PubMed ID: 25027637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of cytogenetics in leukemias.
    VinSheth FJ; Sheth JJ; Patel AI; Shah AD; Verhest A
    Indian J Cancer; 2002; 39(4):139-42. PubMed ID: 12928572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies.
    Wieser R; Schreiner U; Rieder H; Pirc-Danoewinata H; Grüner H; Loncarevic IF; Fonatsch C
    Haematologica; 2003 Jan; 88(1):25-30. PubMed ID: 12551823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
    Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
    Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute leukemia with structural rearrangements of chromosome 3.
    Horsman DE; Gascoyne RD; Barnett MJ
    Leuk Lymphoma; 1995 Feb; 16(5-6):369-77. PubMed ID: 7787746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High expression of interleukin-2 receptor α-chain (CD25) in myelodysplastic syndrome preceding acute myeloid leukemia and chronic myeloid leukemia in myeloid blast crisis.
    Nakase K; Kita K; Kyo T; Katayama N
    Leuk Lymphoma; 2017 May; 58(5):1268-1270. PubMed ID: 27736287
    [No Abstract]   [Full Text] [Related]  

  • 60. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
    Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P
    Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.